Cargando…
miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18
Micro-RNAs play critical roles in initiation and progression of hepatocellular carcinoma. However, the biological role of microRNA-145-5p in hepatocellular carcinoma and how it works are still not clearly understood. Expression levels of microRNA-145-5p in hepatocellular carcinoma cell lines were ex...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535696/ https://www.ncbi.nlm.nih.gov/pubmed/31106707 http://dx.doi.org/10.1177/1533033819850189 |
_version_ | 1783421606524092416 |
---|---|
author | Wang, Baoying Dong, Wenjing Li, Xiaojie |
author_facet | Wang, Baoying Dong, Wenjing Li, Xiaojie |
author_sort | Wang, Baoying |
collection | PubMed |
description | Micro-RNAs play critical roles in initiation and progression of hepatocellular carcinoma. However, the biological role of microRNA-145-5p in hepatocellular carcinoma and how it works are still not clearly understood. Expression levels of microRNA-145-5p in hepatocellular carcinoma cell lines were examined by reverse transcription quantitative polymerase chain reaction. Cell counting kit-8, wound-healing assay, and flow cytometry assay were conducted to investigate the role of microRNA-145-5p von proliferation, migration, and apoptosis. Luciferase reporter assay and Western blot were performed to investigate the correlation between microRNA-145-5p and RAB18. We found microRNA-145-5p was downregulated in hepatocellular carcinoma cell lines compared to the normal cell line. Overexpression of microRNA-145-5p inhibited the proliferation and migration but promoted apoptosis of hepatocellular carcinoma cells in vitro. RAB18 was validated a target of microRNA-145-5p and ectopic expression of RAB18 can promote the proliferation and migration but inhibit apoptosis of hepatocellular carcinoma cells. These findings indicate that microRNA-145-5p functions as a novel tumor suppressor through targeting RAB18, suggesting that microRNA-145-5p might be a potential new therapeutic molecule for the treatment of hepatocellular carcinoma. |
format | Online Article Text |
id | pubmed-6535696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65356962019-06-14 miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18 Wang, Baoying Dong, Wenjing Li, Xiaojie Technol Cancer Res Treat Original Article Micro-RNAs play critical roles in initiation and progression of hepatocellular carcinoma. However, the biological role of microRNA-145-5p in hepatocellular carcinoma and how it works are still not clearly understood. Expression levels of microRNA-145-5p in hepatocellular carcinoma cell lines were examined by reverse transcription quantitative polymerase chain reaction. Cell counting kit-8, wound-healing assay, and flow cytometry assay were conducted to investigate the role of microRNA-145-5p von proliferation, migration, and apoptosis. Luciferase reporter assay and Western blot were performed to investigate the correlation between microRNA-145-5p and RAB18. We found microRNA-145-5p was downregulated in hepatocellular carcinoma cell lines compared to the normal cell line. Overexpression of microRNA-145-5p inhibited the proliferation and migration but promoted apoptosis of hepatocellular carcinoma cells in vitro. RAB18 was validated a target of microRNA-145-5p and ectopic expression of RAB18 can promote the proliferation and migration but inhibit apoptosis of hepatocellular carcinoma cells. These findings indicate that microRNA-145-5p functions as a novel tumor suppressor through targeting RAB18, suggesting that microRNA-145-5p might be a potential new therapeutic molecule for the treatment of hepatocellular carcinoma. SAGE Publications 2019-05-19 /pmc/articles/PMC6535696/ /pubmed/31106707 http://dx.doi.org/10.1177/1533033819850189 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Wang, Baoying Dong, Wenjing Li, Xiaojie miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18 |
title | miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular
Carcinoma Through Targeting RAB18 |
title_full | miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular
Carcinoma Through Targeting RAB18 |
title_fullStr | miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular
Carcinoma Through Targeting RAB18 |
title_full_unstemmed | miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular
Carcinoma Through Targeting RAB18 |
title_short | miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular
Carcinoma Through Targeting RAB18 |
title_sort | mir-145-5p acts as a novel tumor suppressor in hepatocellular
carcinoma through targeting rab18 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535696/ https://www.ncbi.nlm.nih.gov/pubmed/31106707 http://dx.doi.org/10.1177/1533033819850189 |
work_keys_str_mv | AT wangbaoying mir1455pactsasanoveltumorsuppressorinhepatocellularcarcinomathroughtargetingrab18 AT dongwenjing mir1455pactsasanoveltumorsuppressorinhepatocellularcarcinomathroughtargetingrab18 AT lixiaojie mir1455pactsasanoveltumorsuppressorinhepatocellularcarcinomathroughtargetingrab18 |